|Day Low/High||80.72 / 81.31|
|52 Wk Low/High||48.83 / 84.00|
St. Jude Medical's (STJ) price target was cut to $59 from $64 at Canaccord on Thursday.
St. Jude Medical (STJ) shares are lower after the company provided a light guidance for the fourth quarter and lowered its full year 2015 guidance.
Shares of HeartWare dropped yesterday after the announcement that it was probing "reported adverse events" experienced by certain patients who participated in a clinical trial of it's MVAD heart pump.
The most recent short interest data has been released by the NASDAQ for the 09/30/2015 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.
Trade-Ideas LLC identified St Jude Medical (STJ) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
The activist investor is calling for the end of the proposed $860 million deal, vowing to campaign against it and seek board seats if its advice goes unheeded.
Over 1 million babies worldwide are born each year with congenital heart defects (CHD) - the most common birth defect and the most common cause of infant death from birth defects.
St. Jude Medical, Inc.
Medtronic reported good earnings results and the stock can move higher as a result. Conversely, Joy Global seems destined to go lower due to crumbling sales, Cramer says.
The cardiac device company's shares dipped more than 20% on news of the transaction, which could be worth up to $860 million.
Campbell Soup and Medtronic both report their latest quarterly results on Thursday, and Jim Cramer is watching them closely.
Cramer gives his opinion on a slew of stocks as he answers viewers' Twitter questions.
Jim Cramer answered viewers' Twitter from the floor of the New York Stock Exchange, commenting on Qorvo (QRVO), Celgene (CELG), and Boston Scientific (BSX).
In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, St Jude Medical Inc has taken over the #112 spot from EQT Corp. , according to ETF Channel.
Stocks pare gains by Thursday afternoon, even as crude oil closes above $42 a barrel and the energy sector soars.
Stocks climbed early Thursday, but Jim Cramer, portfolio manager of Action Alerts PLUS, remains cautious still.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.